Inventor · disambiguated record
Karen Elizabeth Lackey
Also filed as: LACKEY KAREN E · LACKEY KAREN ELIZABETH · LACKEY Karen
27 granted patents·14 pending applications·1,418 citations·filing 1992–2016
98Inventor score
Files withSMITHKLINE BEECHAM CORP17LACKEY KAREN ELIZABETH5GLAXO WELLCOME INC3NOVARTIS AG3GLAXOSMITHKLINE LLC2
Top patents by PatentIndex Score
41 records- 0198US6727256B1Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitorsSMITHKLINE BEECHAM CORP·Filed 1999·Granted Apr 27, 2004·174 cites·8 claims
- 0298US6713485B2Heterocyclic compoundsSMITHKLINE BEECHAM CORP·Filed 2002·Granted Mar 30, 2004·237 cites·18 claims
- 0397US6369086B1Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitorsSMITHKLINE BEECHAM CORP·Filed 1999·Granted Apr 9, 2002·213 cites·18 claims
- 0496US6815439B2Substituted aza-oxindole derivativesSMITHKLINE BEECHAM CORP·Filed 2003·Granted Nov 9, 2004·53 cites·23 claims
- 0596US6268391B1Benzylidene-1,3-dihydro-indol-2-one derivatives a receptor tyrosine kinase inhibitors, particularly of Raf kinasesGLAXO WELLCOME INC·Filed 1998·Granted Jul 31, 2001·238 cites·26 claims
- 0696US5342947APreparation of water soluble camptothecin derivativesGLAXO INC·Filed 1992·Granted Aug 30, 1994·112 cites·5 claims
- 0795US7105529B2Substituted oxindole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors and compositions and methods of treating chemotherapy and radiation therapy side effectsSMITHKLINE BEECHAM CORP·Filed 2001·Granted Sep 12, 2006·64 cites·5 claims
- 0894US9199973B2Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitorsNOVARTIS AG·Filed 2014·Granted Dec 1, 2015·14 cites·4 claims
- 0994US7084147B2Anilinoquinazaolines as protein tyrosine kinase inhibitorsSMITHKLINE BEECHAM CORP·Filed 2005·Granted Aug 1, 2006·25 cites·29 claims
- 1092US6498176B13-(anilinomethylene) oxindoles as protein tyrosine kinase and protein serine/threonine kinase inhibitorsSMITHKLINEBEECHAM CORP·Filed 2000·Granted Dec 24, 2002·39 cites·17 claims
- 1191US6933299B1Anilinoquinazolines as protein tyrosine kinase inhibitorsSMITHKLINE BEECHAM CORP·Filed 2000·Granted Aug 23, 2005·27 cites·30 claims
- 1289US7141576B2Cancer treatment methodSMITHKLINE BEECHAM CORK LTD·Filed 2002·Granted Nov 28, 2006·68 cites·2 claims
- 1389US6350747B13-(anilinomethylene) oxindolesGLAXO WELLCOME INC·Filed 2000·Granted Feb 26, 2002·38 cites·45 claims
- 1487US6541503B2Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitorsSMITHKLINE BEECHAM CORP·Filed 2001·Granted Apr 1, 2003·22 cites·17 claims
- 1585US8912205B2Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitorsGLAXOSMITHKLINE LLC·Filed 2013·Granted Dec 16, 2014·3 cites·2 claims
- 1685US7189734B2Anilinoquinazaolines as protein tyrosine kianse inhibitorsSMITHKLINE BEECHAM CORP·Filed 2006·Granted Mar 13, 2007·5 cites·25 claims
- 1784US6624171B1Substituted aza-oxindole derivativesSMITHKLINE BEECHAM CORP·Filed 2000·Granted Sep 23, 2003·13 cites·9 claims
- 1883US8513262B2Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitorsCARTER MALCOLM CLIVE·Filed 2010·Granted Aug 20, 2013·5 cites·9 claims
- 1981US7129253B2CompoundsSMITHKLINE BEECHAM CORP·Filed 2003·Granted Oct 31, 2006·14 cites·11 claims
- 2079US6964977B2Oxindole derivativesSMITHKLINE BEECHAM CORP·Filed 2001·Granted Nov 15, 2005·10 cites·9 claims
- 2177US6818632B23-(anilinomethylene)oxindolesSMITHKLINE BEECHAM CORP·Filed 2001·Granted Nov 16, 2004·11 cites·19 claims
- 2277US6100273AWater soluble camptothecin derivativesGLAXO WELLCOME INC·Filed 1997·Granted Aug 8, 2000·22 cites·28 claims
- 2375US7265123B2Heterocyclic compoundsSMITHKLINE BEECHAM CORP·Filed 2006·Granted Sep 4, 2007·1 cites·29 claims
- 2474US7015231B2Chemical compoundsSMITHKLINE BEECHAM CORP·Filed 2002·Granted Mar 21, 2006·8 cites·7 claims
- 2568US8444988B2Cancer treatment methodLACKEY KAREN ELIZABETH·Filed 2011·Granted May 21, 2013·2 cites·4 claims
- 2665US7507741B2Heterocyclic compoundsSMITHKLINE BEECHAM CORP·Filed 2007·Granted Mar 24, 2009·0 cites·8 claims
- 2765US2007238875A1Heterocyclic compoundsCARTER MALCOLM C·Filed 2007·Application pending·0 cites
- 2864US2016339027A1Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitorsNOVARTIS AG·Filed 2016·Application pending·0 cites
- 2963US2007015775A1Heterocyclic compoundsCARTER MALCOM C·Filed 2006·Application pending·0 cites
- 3062US2016051551A1Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitorsNOVARTIS AG·Filed 2015·Application pending·0 cites
- 3161US2008234267A1Compounds and Methods of TreatmentLACKEY KAREN ELIZABETH·Filed 2007·Application pending·0 cites
- 3257US2003176451A1Heterocyclic compoundsFiled 2003·Application pending·0 cites
- 3351US7338966B2Substituted oxindole derivatives as tyrosine kinase inhibitorsSMITHKLINE BEECHAM CORP·Filed 2005·Granted Mar 4, 2008·0 cites·8 claims
- 3451US2011053934A1Compounds and methods of treatmentGLAXOSMITHKLINE LLC·Filed 2010·Application pending·0 cites
- 3550US2007148261A1Cancer treatment methodLACKEY KAREN E·Filed 2006·Application pending·0 cites
- 3648US2005282810A1Oxindole derivativesHARRIS PHILIP A·Filed 2005·Application pending·0 cites
- 3746US2015366868A1Cancer treatment methodLACKEY KAREN ELIZABETH·Filed 2015·Application pending·0 cites
- 3846US2006128745A1Chemical compoundsLACKEY KAREN E·Filed 2006·Application pending·0 cites
- 3944US2011312982A1Cancer Treatment MethodLACKEY KAREN ELIZABETH·Filed 2011·Application pending·0 cites
- 4041US2010249160A1Cancer Treatment MethodLACKEY KAREN ELIZABETH·Filed 2010·Application pending·0 cites
- 4138US2005267133A1Pyrazolopyrimidines as kinase inhibitorsBROWN MATTHEW L·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Karen Elizabeth Lackey files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →